Welcome to Thoracic Surgery

Thoracic Surgery at Weill Cornell Medicine|NewYork-Presbyterian is dedicated to the delivery of the highest quality and advanced care to patients with diseases of the lung, trachea, esophagus, chest wall and mediastinum. Read More.

Learn about the Neuberger Berman Lung Cancer Research Center

NewYork-Presbyterian & Weill Cornell Medicine – Cardiothoracic Surgery

Conditions & Treatments

Our Surgeons

Nasser K. Altorki, M.D.

Jeffrey L. Port, M.D.

Jonathan Villena-Vargas, M.D.

Sebron W. Harrison, M.D.

Benjamin E. Lee, M.D.

Oliver S. Chow, M.D.

Interventional Pulmonologists

Muhammad S. Ali, M.B.B.S.

Eugene Shostak, M.D.

FAQs & Patient Guides

Weill Cornell Medicine Cardiothoracic Surgery 525 East 68th Street
Box 110
Suite M 404 New York, NY 10065 Directions
Phone: (212) 746-5166 Email: ctsurgery@med.cornell.edu

News

Symposium: Advances in Thoracic Oncology

The course is a one day, in depth meeting focused on updating healthcare providers on advances in thoracic oncology. Participants will be able to identify the advances in the management of patients with lung cancer.

For more details: Advances in Thoracic Oncology

Study Looks at the “Harms” of Lung Cancer Screening

By Brendon M. Stiles, MD

May 7, 2018

It was a privilege to present our clinical research, “Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice?” at the 98th American Association of Thoracic Surgery (AATS) Annual Meeting last week in San Diego. I was pleased that the AATS recognized the importance of our message by placing the presentation in one of the featured plenary sessions.

Here is a link to the article: "Study Looks at the "Harms" of Ling Cancer Screening"

Never Smokers: The New Face of Lung Cancer

By Brendon M. Stiles, MD, FACS

March 9, 2018

People often use the expression, “Where there is smoke, there is fire.” Unfortunately for lung cancer patients, the opposite is almost always assumed to be true. Where there is fire (in this case, lung cancer), it is assumed that smoking must have preceded it. This assumption often leads to the question, “Did you smoke?” following almost every personal revelation of lung cancer. Few questions engender such anger and annoyance in patients as that one, particularly in the 10%-20% of lung cancer patients who are “never smokers.”

Here is a link to the article: Never Smokers: The New Face of Lung Cancer